ATLANTA — Latonia Wilkins is aware of she must be on PrEP on account of her non-monogamous way of life. However the 52-year-old Atlanta mom has confronted repeated challenges getting the lifesaving drug that may stop new HIV infections.
Years in the past, Wilkins was courting a person newly recognized with HIV and went to get examined, she stated, however was not supplied PrEP.
Since then, Wilkins stated, docs both have advised her she doesn’t want the drug or had been reluctant to prescribe it. Her insurance coverage by means of work wouldn’t cowl a long-acting injectable kind that tends to have higher outcomes than the unique tablet kind. Attending to appointments throughout Atlanta for the drugs was a problem. She is now enrolled in a drug trial for a promising PrEP injection however worries about future entry and price.
Preexposure prophylaxis, often known as PrEP, reduces the chance of latest HIV infections by means of intercourse by 99% and amongst injectable drug customers by at least 74%, in accordance with the Facilities for Illness Management and Prevention.
Amongst states, Georgia has the highest rate of latest HIV infections, however residents — particularly girls and Black sufferers like Wilkins — are sometimes not getting PrEP, knowledge exhibits.
A rule enacted by the Biden administration that took impact for a lot of Inexpensive Care Act plans on Jan. 1 ought to make it simpler for folks like Wilkins to get long-acting PrEP injectable medication.
A brand new Trump administration provides an X issue to this and different federal well being applications. On Jan. 27, the White Home introduced a federal funding freeze, which despatched shudders by means of well being businesses and nonprofits. By Jan. 29, it had reversed the order.
Federal initiatives just like the Ryan White HIV/AIDS Program and HIV prevention funding appeared to be affected — and “blocking entry to PrEP would have lethal penalties,” stated Wayne Turner, a senior lawyer on the Nationwide Well being Regulation Program.
Georgia has massive racial and gender discrepancies in PrEP uptake, stated Patrick Sullivan, who’s an epidemiology professor at Emory College and leads AIDSVu and PrEPVu, which observe HIV knowledge and entry to the drug — work that’s backed by Gilead Sciences, a PrEP drug producer.
Public well being specialists use what’s referred to as a “PrEP-to-need ratio” to measure how many individuals liable to HIV are getting the drug. The next quantity is healthier. In Georgia for 2023, the statewide ratio was 6, whereas it was almost 167 in Vermont, according to PrEPVu.
Whereas the ratio for white folks in Georgia was roughly 22, it was about 3 for Black folks and simply over 3 for Hispanic folks. And whereas it was 7 for males, it was simply over 2 for girls.
“Black folks typically are underserved by PrEP, and ladies are underserved by PrEP relative to males,” Sullivan stated.
Rising PrEP uptake would assist the state lower its new HIV diagnoses, stated Dylan Baker, affiliate medical director at Grady Well being’s HIV Prevention Program.
Georgia’s charge of latest HIV diagnoses was 27 per 100,000 in 2022, in accordance with the newest obtainable knowledge. That’s second solely to Washington, D.C., and greater than double the nationwide charge of 13 per 100,000. That quantities to about 2,500 new circumstances recognized in Georgia in a 12 months.
Globally about 3.5 million folks used PrEP in 2023, up from 200,000 in 2017 however wanting the United Nations’ 2025 goal of 21.2 million folks, according to a 2024 report by the United Nations Program on HIV/AIDS.
PrEP customers in Atlanta report many challenges in getting the drug, together with price, medical suppliers who don’t prescribe it, stigma, a scarcity of inclusive advertising and marketing, and transportation. Wilkins stated she has run up in opposition to all of these.
“Right here I’m telling you that I’m right here to get examined as a result of I’ve come into contact with somebody who was residing with HIV, and we had a sexual relationship, and also you’re not even mentioning PrEP to me,” Wilkins stated. “That was a disservice.”
Insurers Now Required To Cowl PrEP
Value has lengthy been a barrier. The Biden administration final fall issued guidance requiring most insurers to cowl the total price of all types of PrEP, with out prior authorization, together with sure lab work and different companies. This contains drugs in addition to Apretude, an injection given each two months.
Which means insured PrEP customers shouldn’t face out-of-pocket costs, stated Carl Schmid, govt director of the HIV+Hepatitis Policy Institute, which lobbied for the rule.
It applies to these on the federal market plans and most massive non-public well being plans. A similar rule exists for Medicare and Medicare Advantage plans.
Schmid stated he doesn’t assume the Trump administration will repeal the rule, however he’s involved the U.S. Supreme Courtroom might finish protection for preventive companies, together with PrEP, when it points a choice in Braidwood Management v. Becerra, anticipated this summer season.
The rule won’t assist the uninsured. In Georgia, which didn’t increase Medicaid underneath the ACA, about 1 million adults under age 65 are uninsured.
“The associated fee can be a battle, particularly given totally different persons are a part of the gig economic system, a whole lot of people don’t all the time have entry to medical insurance,” stated Maximillian Boykin, an Atlanta PrEP person.
Increasing Medicaid would assist. States which have finished so, Sullivan stated, “have increased ranges of PrEP uptake.”
Profitable the PrEP Lottery
Since getting on PrEP in 2019, Wilkins has encountered two docs who didn’t wish to prescribe it.
One feminine OB-GYN advised her “‘Lady, at our age, we must always know higher.’” Wilkins stated she “fired” that doctor, telling her that such feedback are stigmatizing.
When Wilkins moved, she seemed for a close-by main care supplier so she wouldn’t need to pay for transportation to get PrEP.
However the physician she discovered, Wilkins stated, advised her to search out an infectious illness specialist for PrEP.
“‘You’re not treating an infectious illness,’ I say. ‘That is preventive care,’” Wilkins recalled.
Wilkins’ fortunes turned when she was chosen to hitch a research for a twice-yearly injectable type of PrEP.
Lenacapavir, already authorised for HIV therapy, confirmed promising outcomes for HIV prevention in two earlier Gilead trials. Wilkins is a part of a trial in Atlanta together with about 250 cisgender girls nationally who’ve intercourse with males.
It’s a lot better than a every day tablet or perhaps a shot as soon as each two months, Wilkins stated.
She hopes to remain on the drug, however the U.S. checklist value for lenacapavir as an HIV therapy averages about $40,000 a 12 months.
Gilead final 12 months introduced it signed royalty-free licensing agreements with six producers to make generic lenacapavir for 120 primarily low- and lower-middle-income nations.
It’s not clear the place it falls with the Biden rule. “We imagine it ought to be coated,” Schmid stated, “however need the federal authorities to state that clearly.”
For a lot of sufferers, challenges stay. Most individuals are keen to journey about half-hour for routine well being care, Sullivan stated, however in cities like Atlanta, these counting on public transportation could face longer commutes to PrEP suppliers. Some who want PrEP have unstable housing with out agency mailing addresses.
Privateness is one other concern. “All people ought to be capable of discover a place that is snug,” Sullivan stated. “Extra of that may go on in main well being care.”
Others agree that public well being messaging round PrEP companies ought to goal extra various audiences. Dázon Dixon Diallo is the founding father of SisterLove, an HIV, sexual, and reproductive well being group centered on Black girls within the Southeast.
“You’re not going to get to us by giving us a 3-second cameo in a business about PrEP,” she stated. “There’s no story in there for me, proper?”
Healthbeat is a nonprofit newsroom protecting public well being printed by Civic News Company and KFF Health News. Join its newsletters here.
